Acrisure Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-9,887
Closed -$743K 51
2023
Q1
$743K Sell
9,887
-5,041
-34% -$375K 0.75% 22
2022
Q4
$1.18M Buy
+14,928
New +$1.12M 1.3% 4

Other funds holding CL

Acrisure Capital Management's CL Position: Q2 2023 in Review

Acrisure Capital Management sold out of Colgate-Palmolive (CL) in Q2 2023, closing a stake of 9,887 shares — an estimated $743K sold.

Acrisure Capital Management first reported a position in CL in Q4 2022 and held it in 2 quarters. The position peaked at $1.18M in Q4 2022. 1,679 funds tracked by Wall St. Rank hold CL as of Q2 2023.

  • Acrisure Capital Management reported no remaining Colgate-Palmolive position as of Q2 2023 after selling out during the quarter.
  • Acrisure Capital Management sold 9,887 Colgate-Palmolive shares in Q2 2023, an estimated $743K.
  • Acrisure Capital Management first reported a position in Colgate-Palmolive in Q4 2022 and held it in 2 quarters.
  • Acrisure Capital Management's Colgate-Palmolive position peaked at $1.18M in Q4 2022.
  • 1,679 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2023.

Based on Acrisure Capital Management's 13F filing for Q2 2023.